Longterm Outcome of Photodynamic Therapy Compared With Chemotherapy Alone in Patients With Advanced Rectal Cancer
Phase 2/Phase 3
25 Years
75 Years
25 Years
75 Years
Not Enrolling
Both
Advanced Rectal Cancer
Both
Advanced Rectal Cancer
Trial Information
Longterm Outcome of Photodynamic Therapy Compared With Chemotherapy Alone in Patients With Advanced Rectal Cancer
Inclusion Criteria:
- 1.Patients with advanced rectal cancer 2.Patients are willing to join in this
clinical trial.
Exclusion Criteria:
- 1.Patients with advanced rectal cancer can not suffer PDT procedure. 2.Allergy to
photosensitizer
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
Survival rate
Outcome Time Frame:
one month
Safety Issue:
No
Authority:
China: Food and Drug Administration
Study ID:
PDT-R-01
NCT ID:
NCT01872104
Start Date:
August 2013
Completion Date:
August 2016
Related Keywords:
- Advanced Rectal Cancer
- rectal cancer
- rectal adenocarcinoma
- photodynamic therapy
- chemothrapy
- Rectal Neoplasms
Name | Location |
|---|
